Defunct Company
Total Trials
3
As Lead Sponsor
As Collaborator
0
Total Enrollment
453
NCT01893190
Safety and Tolerability Study of EG-1962 in Aneurysmal Subarachnoid Hemorrhage
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 30, 2013
Completion: Jan 31, 2016
NCT02790632
Study of EG-1962 Compared to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage
Phase: Phase 3
Start: Jul 31, 2016
Completion: Jun 30, 2018
NCT02893826
Safety/Pharmacokinetic Study Comparing Intracisternal EG-1962 to Standard of Care Enteral Nimodipine in Adults With aSAH
Phase: Phase 1
Start: Sep 30, 2016
Completion: Mar 31, 2018